Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does atorvastatin have expiration date?Supplements to avoid with methotrexate?Spravato's ketamin price 2025?Spravato ketamine treatment esketamine nasal spray evaluation efficacy safety cost rems treatment resistant depression?Dupixent price per month?
See the DrugPatentWatch profile for Cosentyx
Cosentyx (secukinumab) is a monoclonal antibody that blocks interleukin-17A (IL-17A). Because of its immune-modulating effect, live vaccines are generally avoided during treatment.
The prescribing information for immunosuppressive biologics commonly recommends that live attenuated vaccines not be given to patients receiving the drug (or shortly before starting it), since live vaccines can pose a risk in people whose immune response is affected.
Non-live (inactivated) vaccines are usually considered acceptable, though it’s still best to confirm with your clinician or pharmacist because vaccine timing may matter around biologic dosing.
If live vaccination is needed, clinicians typically try to complete it before starting Cosentyx and allow enough time for the vaccine response to develop. The exact timing should follow the vaccine product guidance and your prescriber’s plan.
Before getting any vaccine, tell the vaccination provider and your prescribing clinician that you take Cosentyx, and ask specifically whether the vaccine is live or non-live and whether you need a scheduling adjustment.
Other Questions About Cosentyx :